EUROmediCAT signal detection: an evaluation of selected congenital anomaly‐medication associations

AIMS: To evaluate congenital anomaly (CA)‐medication exposure associations produced by the new EUROmediCAT signal detection system and determine which require further investigation. METHODS: Data from 15 EUROCAT registries (1995–2011) with medication exposures at the chemical substance (5th level of...

Descripción completa

Detalles Bibliográficos
Autores principales: Given, Joanne E., Loane, Maria, Luteijn, Johannes M., Morris, Joan K., de Jong van den Berg, Lolkje T.W., Garne, Ester, Addor, Marie‐Claude, Barisic, Ingeborg, de Walle, Hermien, Gatt, Miriam, Klungsoyr, Kari, Khoshnood, Babak, Latos‐Bielenska, Anna, Nelen, Vera, Neville, Amanda J., O'Mahony, Mary, Pierini, Anna, Tucker, David, Wiesel, Awi, Dolk, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Pharmacoepidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137835/
https://www.ncbi.nlm.nih.gov/pubmed/27028286
http://dx.doi.org/10.1111/bcp.12947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137835/
https://www.ncbi.nlm.nih.gov/pubmed/27028286
http://dx.doi.org/10.1111/bcp.12947

Ejemplares similares